+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antithyroid Preparations Market - Global Forecast 2026-2032- Product Image
Antithyroid Preparations Market - Global Forecast 2026-2032- Product Image
Sale

Antithyroid Preparations Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6145615
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Antithyroid Preparations Market is projected to reach USD 1.86 Billion in 2026. It is expected to continue growing at a CAGR of 5.31%, reaching USD 2.57 Billion by 2032.

Antithyroid Preparations: Executive Overview

Antithyroid preparations are medicines used to reduce thyroid hormone production, primarily in hyperthyroidism and Graves’ disease. Clinical selection depends on disease severity, patient age, pregnancy status, liver function, comorbidities, treatment goals, and local prescribing guidance. Common therapeutic approaches include thionamides, radioactive iodine, and surgery, although these options differ in mechanism, monitoring requirements, contraindications, and suitability for individual patients.

Treatment Pathways Are Becoming More Individualized

The treatment landscape is shifting from one-size-fits-all prescribing toward risk-based care. Clinicians increasingly weigh remission prospects, adverse-event risks, pregnancy considerations, definitive-treatment preferences, and the need for long-term biochemical monitoring. Safety surveillance remains central because antithyroid medicines can cause clinically important reactions, including agranulocytosis and hepatotoxicity. Clear patient education about warning symptoms and prompt laboratory assessment is therefore integral to responsible use.

Artificial Intelligence Supports Monitoring and Clinical Decision-Making

Artificial intelligence can strengthen antithyroid-care workflows by identifying patients who may need thyroid-function testing, flagging medication-related risk patterns, supporting interpretation of serial laboratory results, and helping prioritize follow-up. Its value is cumulative when integrated with electronic records, pharmacy data, clinical guidelines, and patient-reported symptoms. Human oversight remains essential because treatment decisions require contextual judgment, validated evidence, privacy safeguards, and careful management of algorithmic bias.

Regional Insights: Access, Monitoring, and Care Delivery Differ

North America generally emphasizes guideline-driven management, laboratory monitoring, and shared decision-making, while Latin America faces uneven access and differences in specialist availability. Europe combines mature clinical guidance with varied national reimbursement and prescribing systems. The Middle East is shaped by expanding specialist capacity, referral patterns, and healthcare-system variation. Africa continues to encounter diagnostic, laboratory, and medicine-access constraints in several settings. Asia-Pacific spans highly developed systems and rapidly expanding care networks, making workforce capacity, affordability, and continuity of monitoring important priorities.

Group Insights: Regional Blocs Shape Standards and Access

ASEAN markets reflect substantial diversity in healthcare financing, specialist access, and regulatory implementation. BRICS members differ widely in manufacturing capacity, public procurement, diagnostic infrastructure, and treatment pathways. The European Union benefits from shared regulatory principles but retains national differences in reimbursement and service delivery. G7 systems generally have stronger clinical infrastructure and pharmacovigilance capabilities, though affordability and care coordination remain relevant. GCC countries often combine well-resourced urban services with a focus on specialist-led care, while NATO members span diverse health systems and preparedness priorities that influence supply resilience and continuity of treatment.

Country Insights: Distinct Health-System Priorities

Australia and Canada prioritize guideline-based care across geographically dispersed populations. Brazil and Mexico must address regional disparities in specialist access and diagnostic follow-up. China and India combine substantial clinical demand with differences between urban and rural services. France, Germany, Italy, Spain, and the United Kingdom operate within established European care frameworks while differing in reimbursement, referral pathways, and prescribing practice. Japan and South Korea emphasize specialist monitoring and structured healthcare delivery. Russia’s care environment is shaped by domestic access, procurement, and regional service variation. The United States places strong emphasis on adverse-event monitoring, specialist care, and treatment choice, alongside persistent affordability and access considerations.

Priorities for Leaders: Strengthen Safety, Access, and Continuity

Industry leaders should align product strategy with evidence-based treatment pathways and provide practical tools for thyroid-function monitoring, adverse-event recognition, and adherence support. Partnerships with clinicians, pharmacies, laboratories, and public health systems can improve continuity of care, particularly where specialist access is limited. Digital and AI-enabled services should be introduced with clinical validation, transparent governance, cybersecurity controls, and human review. Supply planning should prioritize quality assurance, regulatory compliance, and resilience across diverse procurement channels. Patient-facing education should use clear language and reinforce the need to seek urgent evaluation for serious warning symptoms.

Research Methodology: Evidence-Led Market Assessment

This executive summary applies a structured review of established clinical practice, medicine-safety principles, healthcare-system characteristics, regulatory considerations, and regional access conditions relevant to antithyroid preparations. The assessment integrates the specified regional, group, and country geographies without using market estimates, market sizing, market shares, forecasts, or company-specific claims. Interpretations are framed as qualitative insights and should be validated against current national guidelines, regulatory communications, pharmacovigilance findings, and local prescribing information before operational use.

Conclusion: Safe, Context-Aware Management Remains Central

The antithyroid preparations landscape is defined by individualized treatment, vigilant safety monitoring, and uneven access to diagnosis and follow-up. Regional and country differences make adaptable care models essential, while artificial intelligence offers useful support for surveillance and workflow prioritization when properly governed. Sustainable progress depends on evidence-based prescribing, reliable diagnostics, patient education, resilient supply, and coordination among clinicians, regulators, health systems, and communities.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Antithyroid Preparations Market, by Drug Type
7.1. Introduction
7.2. Carbimazole
7.3. Methimazole
7.4. Propylthiouracil
8. Antithyroid Preparations Market, by Product Form
8.1. Introduction
8.2. Injectables
8.3. Liquids
8.4. Tablets
9. Antithyroid Preparations Market, by Product Type
9.1. Introduction
9.2. Branded
9.3. Generic
10. Antithyroid Preparations Market, by Indication
10.1. Introduction
10.2. Graves Disease
10.3. Toxic Nodular Goiter
11. Antithyroid Preparations Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Antithyroid Preparations Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Antithyroid Preparations Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Antithyroid Preparations Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Antithyroid Preparations Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Amneal Pharmaceuticals LLC
17.3. Aurobindo Pharma Ltd.
17.4. Bayer AG
17.5. Bio-T Ltd.
17.6. Cadila Healthcare Ltd.
17.7. Cipla Limited
17.8. Dr. Reddy’s Laboratories Ltd.
17.9. Emcure Pharmaceuticals Ltd.
17.10. Gland Pharma Ltd.
17.11. GlaxoSmithKline plc
17.12. Haffkine Bio-Pharmaceutical Corporation Ltd.
17.13. Intas Pharmaceuticals Ltd.
17.14. Ipca Laboratories Ltd.
17.15. Lannett Company, Inc.
17.16. Lupin Limited
17.17. Merck & Co., Inc.
17.18. Mylan N.V.
17.19. Novartis International AG
17.20. Orion Corporation
17.21. Pfizer Inc.
17.22. Piramal Enterprises Ltd.
17.23. Sanofi S.A.
17.24. Strides Pharma Science Ltd.
17.25. Sun Pharmaceutical Industries Ltd.
17.26. Teva Pharmaceutical Industries Ltd.
17.27. The Procter & Gamble Company
17.28. Torrent Pharmaceuticals Ltd.
17.29. Uni-Sankyo Ltd.
17.30. Wockhardt Ltd.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Antithyroid Preparations Market, Years Considered for the Study
FIGURE 2. Global Antithyroid Preparations Market, Research Design
FIGURE 3. Global Antithyroid Preparations Market, Research Framework
FIGURE 4. Global Antithyroid Preparations Market, Data Triangulation
FIGURE 5. Global Antithyroid Preparations Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Antithyroid Preparations Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 7. Global Antithyroid Preparations Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Antithyroid Preparations Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 9. Global Antithyroid Preparations Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Antithyroid Preparations Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 11. Global Antithyroid Preparations Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Antithyroid Preparations Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 13. Global Antithyroid Preparations Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Antithyroid Preparations Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Antithyroid Preparations Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Antithyroid Preparations Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Antithyroid Preparations Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Antithyroid Preparations Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Antithyroid Preparations Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Antithyroid Preparations Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Antithyroid Preparations Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Antithyroid Preparations Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Antithyroid Preparations Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Antithyroid Preparations Market Segmentation & Coverage
TABLE 2. Global Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 3. Global Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 4. Global Carbimazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Carbimazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Carbimazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Methimazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Methimazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Methimazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Propylthiouracil Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Propylthiouracil Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Propylthiouracil Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 14. Global Injectables Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Injectables Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Injectables Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Liquids Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Liquids Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Liquids Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 24. Global Branded Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Branded Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Branded Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 31. Global Graves Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Graves Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Graves Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Toxic Nodular Goiter Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Toxic Nodular Goiter Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Toxic Nodular Goiter Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 38. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 48. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Antithyroid Preparations Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Antithyroid Preparations Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 65. North America Antithyroid Preparations Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. North America Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 67. North America Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 68. North America Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 69. North America Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 70. North America Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. North America Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. Latin America Antithyroid Preparations Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Latin America Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 74. Latin America Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 75. Latin America Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 76. Latin America Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 77. Latin America Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. Latin America Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 79. Europe Antithyroid Preparations Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Europe Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 81. Europe Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 82. Europe Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 83. Europe Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 84. Europe Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Europe Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 86. Middle East Antithyroid Preparations Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Middle East Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 88. Middle East Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 89. Middle East Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. Middle East Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 91. Middle East Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Middle East Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. Africa Antithyroid Preparations Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Africa Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 95. Africa Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 96. Africa Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. Africa Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 98. Africa Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Africa Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. Global Antithyroid Preparations Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. ASEAN Antithyroid Preparations Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. ASEAN Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 103. ASEAN Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 104. ASEAN Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 105. ASEAN Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 106. ASEAN Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. ASEAN Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. GCC Antithyroid Preparations Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. GCC Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 110. GCC Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 111. GCC Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 112. GCC Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 113. GCC Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. GCC Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. European Union Antithyroid Preparations Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. European Union Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 117. European Union Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 118. European Union Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. European Union Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 120. European Union Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. European Union Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. BRICS Antithyroid Preparations Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. BRICS Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 124. BRICS Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 125. BRICS Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. BRICS Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 127. BRICS Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. BRICS Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. G7 Antithyroid Preparations Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. G7 Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 131. G7 Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 132. G7 Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. G7 Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 134. G7 Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. G7 Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. NATO Antithyroid Preparations Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. NATO Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 138. NATO Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 139. NATO Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. NATO Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 141. NATO Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. NATO Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 143. Global Antithyroid Preparations Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. United States Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 145. United States Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 146. United States Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 147. United States Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. United States Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 149. United States Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. United States Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 151. Canada Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 152. Canada Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 153. Canada Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 154. Canada Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. Canada Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 156. Canada Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Canada Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 158. Mexico Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 159. Mexico Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 160. Mexico Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 161. Mexico Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 162. Mexico Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 163. Mexico Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Mexico Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 165. Brazil Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 166. Brazil Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 167. Brazil Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 168. Brazil Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. Brazil Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 170. Brazil Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. Brazil Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. United Kingdom Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 173. United Kingdom Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 174. United Kingdom Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 175. United Kingdom Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. United Kingdom Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 177. United Kingdom Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. United Kingdom Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. Germany Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 180. Germany Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 181. Germany Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 182. Germany Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. Germany Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 184. Germany Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. Germany Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. France Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 187. France Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 188. France Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 189. France Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. France Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 191. France Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. France Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 193. Russia Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 194. Russia Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 195. Russia Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 196. Russia Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. Russia Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 198. Russia Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Russia Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. Italy Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 201. Italy Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 202. Italy Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 203. Italy Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 204. Italy Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 205. Italy Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Italy Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. Spain Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 208. Spain Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 209. Spain Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 210. Spain Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 211. Spain Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 212. Spain Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Spain Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. China Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 215. China Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 216. China Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 217. China Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. China Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 219. China Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. China Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. India Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 222. India Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 223. India Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 224. India Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 225. India Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 226. India Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. India Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. Japan Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 229. Japan Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 230. Japan Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 231. Japan Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. Japan Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 233. Japan Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. Japan Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 235. Australia Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 236. Australia Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 237. Australia Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 238. Australia Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. Australia Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 240. Australia Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Australia Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 242. South Korea Antithyroid Preparations Market Size, 2017-2032 (USD Million)
TABLE 243. South Korea Antithyroid Preparations Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 244. South Korea Antithyroid Preparations Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 245. South Korea Antithyroid Preparations Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 246. South Korea Antithyroid Preparations Market Size, by Indication, 2017-2032 (USD Million)
TABLE 247. South Korea Antithyroid Preparations Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. South Korea Antithyroid Preparations Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 249. Global Antithyroid Preparations Market Share, by Key Player, 2025
TABLE 250. Global Antithyroid Preparations Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Bio-T Ltd.
  • Cadila Healthcare Ltd.
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Emcure Pharmaceuticals Ltd.
  • Gland Pharma Ltd.
  • GlaxoSmithKline plc
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Intas Pharmaceuticals Ltd.
  • Ipca Laboratories Ltd.
  • Lannett Company, Inc.
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis International AG
  • Orion Corporation
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Sanofi S.A.
  • Strides Pharma Science Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • The Procter & Gamble Company
  • Torrent Pharmaceuticals Ltd.
  • Uni-Sankyo Ltd.
  • Wockhardt Ltd.

Related Topics

Related Reports

Carbimazole Market - Global Forecast 2026-2032 - Product Image

Carbimazole Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Graves Disease Market - Global Forecast 2026-2032 - Product Image

Graves Disease Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Thyroid Gland Disorder Treatment - Global Strategic Business Report - Product Image

Thyroid Gland Disorder Treatment - Global Strategic Business Report

  • Report
  • 224 Pages
  • Global
From
Endocrinology Drugs Market Report 2026 - Product Image

Endocrinology Drugs Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Graves Disease Overactive Thyroid Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Graves Disease Overactive Thyroid Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.